This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
in chemistry from John Hopkins University to help clients ensure their life-saving drugs and inventions go to market. Culhane’s work entails counseling on patentprosecution, duediligence, and patentability and freedom-to-operate matters. Crystal Culhane draws upon her Ph.D.
The diverse group represents clients across a range of industries and brings deep expertise in litigation, patentprosecution, post-grant proceedings and copyright and trademark counseling to their new roles. Dr. Yao Wang focuses on post-grant proceedings, patentprosecution, client counseling, and portfolio development.
has established herself as a go-to attorney for pharmaceutical, chemistry, biotechnology, and nanotechnology clients who depend on her to help bring their life-saving drugs and inventions to market. Culhane is a key advisor on patentprosecution, duediligence and patentability, and freedom-to-operate matters.
In a similar case, the Judge observed that “ If inventors, who seek to inventpatents, are going to suffer such treatment, it would ultimately disincentivize persons from exercising their inventive faculties and coming with new and innovative technologies which would ultimately be deleterious to the national interest as well.
We organize all of the trending information in your field so you don't have to. Join 9,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content